Melissa P Mitchell, MD, PhD
Department of Breast Radiation Oncology, Division of Radiation Oncology
About Melissa P Mitchell
Dr. Mitchell treats all types of breast cancer and is interested in developing a tailored radiation approach for each patient based on stage and tumor biology. With an interest in treatment de-escalation, Dr. Mitchell has performed funded research to assess whether radiosensitivity could be utilized for clinical decision making for adjuvant radiation in patients with ductal carcinoma in situ. Dr. Mitchell has developed a clinical trial to eliminate radiation as a component of treatment for early-stage patients with her-2 positive breast cancer who have an excellent response to treatment. She has also served as the principal investigator on a clinical trial of hypofractionation in locally advanced breast cancer, treating patients with radiation therapy at a reduced total dose and with shorter treatment time, in the hopes of reducing treatment-related toxicity, such as lymphedema. With a background in pharmacology, she also has an interest in combining new pharmaceutical agents with radiation in patients with more aggressive tumors that show evidence of radiation resistance. Furthermore, she is interested in patient quality of life and is working on developing a new validated tool to assess patient-reported toxicity in patients undergoing breast radiotherapy.
Read More
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Breast Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2006 | University of Colorado School of Medicine, Denver, Colorado, US, MD |
| 2004 | University of Colorado School of Medicine, Denver, Colorado, US, Pharmacology, Ph.D |
| 1999 | Northwestern University, Evanston, Illinois, US, Dual degree in Biology and Integrated Science Program, BA |
Postgraduate Training
| 2011-2012 | Clinical Fellowship, Radiation Oncology, M.D. Anderson Cancer Center, Houston |
| 2007-2011 | Clinical Residency, Radiation Oncology, University of Kansas, Kansas City, Kansas |
| 2006-2007 | Clinical Internship, Internal Medicine, University of Kansas, Kansas City, Kansas |
Licenses & Certifications
| 2022 | Georgia Composite Medical Board |
| 2022 | Oklahoma State Board of Medical Licensure |
| 2022 | Tennessee Board of Medical Examiners |
| 2022 | Louisiana State Board of Medical Examiners |
| 2022 | Arizona Board of Medical Examiners |
| 2022 | Alabama Board of Medical Examiners |
| 2022 | Mississippi State Board of Medical Licensure |
| 2021 | Florida Board of Medicine |
| 2019 | Texas Medical Board |
| 2012 | American Board of Radiology |
| null | DEA |
| null | Basic Life Support |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Department of Radiation Oncology, The University of Kansas, Kansas City, KS, 2012 - 2019
Administrative Appointments/Responsibilities
Operations, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Associate Medical Director, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Radiation Oncology Compensation Committee, Department of Radiation Oncology, The University of Kansas Cancer Center, Kansas City, KS, 2018 - 2019
Physician lead for Clinical Operations, Department of Radiation Oncology, The University of Kansas Cancer Center, Kansas City, KS, 2016 - 2019
Executive Committee for Radiation Oncology, Department of Radiation Oncology, The University of Kansas Cancer Center, Kansas City, KS, 2015 - 2019
Other Professional Positions
Volunteer Faculty, UH College of Medicine, Houston, TX, 2023 - 2019
Consultant, Hylapharm, Lawrence, KS, 2018 - 2019
Program Evaluation Committee Chair, The University of Kansas Cancer Center, Kansas City, KS, 2017 - 2019
Physician Recruitment Committee, The University of Kansas Cancer Center, Kansas City, KS, 2015 - 2016
Research Committee Leader, The University of Kansas Cancer Center, Kansas City, KS, 2015 - 2016
Cancer Service Line member/Steering Committee, The University of Kansas Cancer Center, Kansas City, KS, 2015 - 2019
Program Evaluation Committee Member, The University of Kansas Cancer Center, Kansas City, KS, 2013 - 2019
Intramural Institutional Committee Activities
Board Member, Technology Assessment Committee (TAC), The University of Texas MD Anderson Cancer Center, 2025 - Present
Representative, MD Anderson Clinical Operations, The University of Texas MD Anderson Cancer Center, 2025 - Present
Extramural Institutional Committee Activities
Department Representative, Advanced Breast Cancer, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Comparative Plan Request Automation Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Invasive Lobular working group, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, X-met Pillar Working Group, The University of Texas MD Anderson Cancer Center, 2023 - 2024
Member, Breast Planning Directive and Contour Standardization Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Particle Therapy Task Clinical Working Group, The University of Texas MD Anderson Cancer Center, 2022 - Present
Faculty Informal Interviews, Residency Selection Committee, The University of Texas MD Anderson Cancer Center, 2021 - 2023
Member, Breast One RO Standardization Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Department of Radiation Oncology Lead, Joint Plastic Surgery | Breast Surgery | Radiation Oncology Conference Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Radiation Oncology Lead, Institutional Breast Algorithms Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Bone Metastasis Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Medical Practice Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Diversity Recruitment, The University of Kansas Hospital, 2017 - 2018
Member, Hospital Cohort Nominating Committee, University of Kansas, 2017
Radiation Oncology Lead, National Accreditation of Programs in Breast Cancer Committee, The University of Kansas Cancer Center, 2016 - 2019
Second Line Representative, Committee on Cancer, The University of Kansas Cancer Center, 2015 - 2019
Committee Leader, Department of Radiation Oncology, Breast Cancer Radiation Oncology Guidelines, The University of Kansas Cancer Center, 2015 - 2016
Member, Physician EMR Executive Committee (eIPAC), The University of Kansas Hospital, 2015 - 2016
Co-Chair, Breast Disease Working Group, The University of Kansas Cancer Center, 2013 - 2019
Breast Cancer Lead, Department of Radiation Oncology, Mock Oral Examination Workshop, The University of Kansas Cancer Center, 2013 - 2019
Editorial Activities
Associate Editor Breast Track, Practical Radiation Oncology, 2018 - Present
Honors & Awards
| 2022 | Excellence in Safety Award, MD Anderson Cancer Center |
| 2019 | Educator of the Year, ARRO |
| 2019 | Featured article in the Springer column, ASCO |
| 2018 | Nomination for Phase I Committee, KUMC School of Medicine |
| 2018 | Top Doctors in Kansas City, Ingram’s Magazine |
| 2017 | SWOG Travel Grant, SWOG |
| 2014 | Nomination for Gold Humanism Honor Society, Gold Humanism Honor Society |
| 2009 | Second place poster award in biology, ASTRO |
| 2002 - 2006 | Individual NRSA fellowship grant, NIEHS |
| 1999 | Graduate Merit Training Grant |
| 1999 | IBM Grant for Women in Research, Women in Research |
| 1998 | Erwin Macy Scholarship |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. Postmastectomy Radiation Therapy: A ASTRO/ASCO/SSCO Clinical Practice Guideline. Invited. Podcast. Houston, Texas, US.
- 2025. Updates on Advanced Breast Cancer: Local Management and Other New Perspectives. Invited. Houston, Texas, US.
- 2024. Multidisciplinary approaches to SLN and ALND omission based on the SOUND, SENOMAC AND AMAROS trials. Panelist. Breast Cancer Clinical and Translational Research (BCCTR) Conference. Houston, Texas, US.
- 2024. Timing Matters: Integrating Breast Reconstruction and Adjuvant Therapies. Houston, Texas, US.
- 2024. Radiation Oncology Perspective of ILC Treatment. Invited. Houston, Texas, US.
- 2023. Axillary Management with Mastectomy in cN0 patients. Invited. Radiation Oncology Perspective BCCTR. Houston, Texas, US.
- 2023. SABCS Review. Invited. Houston, Texas, US.
- 2022. Treatment De-escalation: What does the data tell us?. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2021. Practical Radiation Oncology, "Fast" Breast Irradiation – Opportunities and Unknowns of Whole and Partial Treatment Options. Invited. Podcast. Houston, Texas, US.
National Presentations
- 2025. Debate – Cons of Protons for Breast Cancer. Invited. PTCOG-NA 11th Annual Meeting. Shreveport, Louisiana, US.
- 2025. Eliminating Radiotherapy in Exceptional Responders. Invited. Rush Cancer Symposium. Chicago, Illinois, US.
- 2025. Biologically informed radiotherapy for breast cancer. ARS 107th Annual Meeting. Seattle, Washington, US.
- 2023. Automated Planning and Contouring. Conference. DAVA Oncology, US.
- 2023. Omission of RT in exceptional responders. Conference. DAVA Oncology, HI, US.
- 2023. Use of genomic assays to guide RT. Conference. DAVA Oncology, US.
- 2022. The role of advanced radiation technology in reducing toxicity. Invited. SABCS. San Antonio, TX, US.
- 2021. Genomic Profiling and Radiosensitivity. Conference. MJH Life Sciences. Dallas, US.
- 2021. Genomic Profiling and Radiosensitivity. Conference. MJH life sciences. Orlando, US.
- 2019. Reconstruction: A Multidisciplinary Approach. Invited. Plastic Surgery the Meeting. San Diego, CA, US.
International Presentations
- 2025. Role of Radiotherapy in Stage IV Breast Cancer. Invited. Indonesia, US.
- 2025. Can Radiation Replace Axillary Dissection in Patients with Persistent Node Positive Disease after Neoadjuvant Chemotherapy. Invited. Oaxaca, MX.
- 2025. Debate – Pros of Radiotherapy for DCIS. Invited. Oaxaca, MX.
- 2025. Radiation Decisions in the Setting of Sentinel Node Biopsy Omission. Invited. Oaxaca, MX.
- 2024. Treatment Strategy for Axillary Lymph Node of Breast Cancer (Surgery or Radiotherapy?). Invited. CCMC Symposium 2024, CN.
- 2024. Elimination of Radiotherapy After Neoadjuvant Systemic Treatments. Invited, MX.
- 2024. Elimination of breast surgery after systemic treatment. Invited. National Congress, MX.
- 2024. Elimination of breast surgery after systemic treatment. Invited. CCCM Symposium 2024, CN.
- 2024. Radiation Oncology: Hypofractionation vs conventional radiotherapy after breast cancer surgery. Invited, ID.
- 2024. Evidence Supporting the Use of Particle Therapy to Reduce Cardiac Exposure in Breast Malignancies. Invited. 62nd Annual PTCOG Conference & 4th PTCOG-AO Meeting, SG.
- 2024. De-escalation of Breast Radiation in the Era of Improved Systemic Therapy and Genomic Profiling. Invited. IOSC 2024, AE.
- 2024. IMPT for breast cancer role in dermatitis reduction and integration of DIBH. Invited. Guangzhou, CN.
- 2023. Use of Protons for Breast Radiotherapy. Conference. MDACC/CCM Joint Academic Conference, US.
Grant & Contract Support
| Date: | 2025 - 2028 |
| Title: | AI-based end-to-end radiotherapy planning for breast cancer: Prospective evaluation and risk reduction |
| Funding Source: | Cancer Prevention Research Institute of Texas |
| Role: | Co-I |
| ID: | RP260167 |
| Date: | 2023 - 2024 |
| Title: | Artidis Alliance Project 2016-0046 |
| Funding Source: | Artidis |
| Role: | Subaward Investigator |
| ID: | AWD00007031, RCTS#00061840 |
| Date: | 2021 |
| Title: | Radioresistance of Ductal Carcinoma in Situ Versus Invasive Breast Carcinoma, NCI Clinical and Translational Exploratory/Developmental Studies |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | PAR-20-292 |
| Date: | 2019 - 2020 |
| Title: | The Grand Challenge: When is Cancer Not Cancer |
| Funding Source: | UK PRECISION |
| Role: | Co-I |
| Date: | 2019 - 2019 |
| Title: | Breast Cancer Fatigue and Mitochondrial Gene Expression in Black and White Women |
| Funding Source: | KUCC Pilot Project |
| Role: | Co-I |
| Date: | 2016 - 2018 |
| Title: | Qigong Intervention for Breast Cancer Survivors with Complaints of Decreased Cognitive Function |
| Funding Source: | Oncology Nursing Society Foundation Nursing |
| Role: | Co-I |
| Date: | 2013 - 2014 |
| Title: | Development of a Radiosensitivity Assay for DCIS |
| Funding Source: | KU Cancer Center |
| Role: | PI |
| Date: | 2002 - 2006 |
| Title: | F30ES012347 NRSA fellowship grant awarded from the NIEHS, Signaling Mechanisms of Ozonized Pulmonary Surfactant |
| Funding Source: | NIH/NIEHS |
| Role: | PI |
| Title: | Fatigue, quality of life, and leukocyte transcriptomes in black and white breast cancer patients |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Title: | Breast Cancer Research Program Breakthrough Award Level 1 |
| Funding Source: | Department of Defense (DOD) |
| Role: | PI |
| Title: | Measurement of Cognitive Effort for Breast Cancer Survivors |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Title: | Development of a Radiosensitivity Assay for Clinical Use in DCIS |
| Funding Source: | American Cancer Society (ACS) |
| Role: | PI |
| Title: | Psychoneurological Symptom Cluster, Lifetime Stress Exposure and Radiation Treated Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
Selected Publications
Peer-Reviewed Articles
- Azhar, M, Soto, F, Su, A, Gonzalez, NV, Medina, KB, Madrigal, AL, Duran, CC, Reyna, CR, Chan, C, Shroff, G, Bassett Jr, R, Pasyar, S, Zhang, D, Shannon, VR, Altan, M, Mitchell, MP, Meric-Bernstam, F, Mouabbi, JA, Murthy, RK, Faiz, S, Bashoura, L, Lim, B, Sheshadri, A. Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer. Breast Cancer Research 27(1), 2025. e-Pub 2025. PMID: 41194091.
- Yi, M, Chavez Mac Gregor, M, Smith, B, Mitchell, MP, Caudle, AS, DeSnyder, SM, Kuerer, HM, Hunt, KK. Comparing Survival Differences between Patients Undergoing Breast-Conserving Therapy Versus Total Mastectomy as a First Treatment for Early Stage Breast Cancer. Annals of surgical oncology 32(13):9757-9766, 2025. e-Pub 2025. PMID: 40789993.
- Clemens, MW, Mitchell, MP, Christensen, JM, Olenczak, JB, Shay, PL, Hanwright, P, Ha, A, Kapur, SK, Melancon, AD, Shuck, JW. Magnetic Resonance Imaging-Conditional Tissue Expanders in Breast Reconstruction. Plastic and reconstructive surgery 156(2):225-233, 2025. e-Pub 2025. PMID: 39946673.
- Jacomina, LE, Swanson, DM, Mitchell, MP, Woodward, W, Smith, B, Hoffman, K, Goodman, C, Garber, HR, Sun, SX, Yap, TA, Meric-Bernstam, F, Arzu, I, Bloom, ES, Schlembach, PJ, Strom, EA, Stauder, MC, Shaitelman, SF. Outcomes After Palliative Radiation Therapy in Patients With Symptomatic Locoregionally Advanced Breast Cancer. International Journal of Radiation Oncology Biology Physics 122(2):278-291, 2025. e-Pub 2025. PMID: 39549757.
- Wanis, K, Mitchell, MP, Giordano, SH, Litton, J, Shaitelman, SF, Tamirisa, N, Bedrosian, I, Dong, W, Shen, Y, Hunt, KK, Singh, P, Sun, SX, Caudle, AS, Kuerer, HM, Meric-Bernstam, F, Hwang, RF, Adesoye, T. Implications of omitting sentinel lymph node biopsy on adjuvant decision making for patients with small breast cancers. Cancer 131(11), 2025. e-Pub 2025. PMID: 40433858.
- Kuerer, HM, Valero, V, Smith, BD, Krishnamurthy, S, Diego, EJ, Johnson, HM, Lin, Y, Shen, Y, Lucci, A, Shaitelman, SF, Mitchell, MP, Boughey, JC, White, RL, Hunt, KK, Yang, WT, Rauch, GM, Moseley, T, Leung, J, Huang, ML, Candelaria, RP, Adrada, BE, Arribas, E, van la Parra, RF, Ramirez, DL, Teshome, M, Hwang, RF, Miggins, MV, Piotrowski, MJ, Correa Refinetti, AP, Ehlers II, RA, Mouabbi, JA, Colen, JS, Loveland-Jones, C, Lesnikowski, BA, Samiian, L, Chong, C, Black, DM, Desyder, SM, Sun, SX, Nguyen, TM. Selective Elimination of Breast Surgery for Invasive Breast Cancer A Nonrandomized Clinical Trial. JAMA Oncology 11(5):529-534, 2025. e-Pub 2025. PMID: 40152443.
- Reddy, JP, Sherry, AD, Fellman, B, Liu, S, Bathala, TK, Haymaker, CL, Cohen, L, Smith, B, Ramirez, DL, Shaitelman, SF, Chun, SG, Medina-Rosales, M, Teshome, M, Brewster, A, Barcenas, CH, Reuben, A, Ghia, AJ, Ludmir, EB, Weed, D, Shah, SJ, Mitchell, MP, Woodward, W, Gomez, D, Tang, C. Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND). International Journal of Radiation Oncology Biology Physics 121(4):885-893, 2025. e-Pub 2025. PMID: 39486645.
- Baroudi, H, Che Fru, L, Schofield, D, Roniger, DL, Nguyen, C, Hancock, D, Chung, CV, Beadle, BM, Gifford, KA, Netherton, T, Niedzielski, JS, Melancon, AD, Muruganandham, M, Khan, M, Shaitelman, SF, Shete, S, Murina, P, Venencia, D, Thengumpallil, S, Vrieling, C, Zhang, J, Mitchell, MP, Court, LE. An automated treatment planning portfolio for whole breast radiotherapy. Medical physics 52(3):1779-1788, 2025. e-Pub 2025. PMID: 39699058.
- Braunstein, L, Mitchell, MP, Bandos, H, Sikov, W, Khan, AJ, Chen, PY, Ganz, PA, Jagsi, R, White, J, Cecchini, RS, Kang, H, Puhalla, S, Bolton, KL, Connolly, E, Stringer-Reasor, E, Gergelis, KR, Julian, TB, Mamounas, EP, Wolmark, N. A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO). Journal of Clinical Oncology 43(16), 2025. e-Pub 2025. PMID: 40574381.
- Braunstein, L, Mitchell, MP, Bandos, H, Sikov, W, Khan, AJ, Chen, PY, Ganz, PA, Jagsi, R, White, J, Cecchini, RS, Kang, H, Puhalla, S, Bolton, KL, Connolly, E, Stringer-Reasor, E, Gergelis, KR, Julian, TB, Mamounas, EP, Wolmark, N. NRG-BR008/HERO study. Future Oncology 21(16):2017-2025, 2025. e-Pub 2025. PMID: 40574381.
- Mitchell, MP, Shaitelman, SF, Smith, BD, Krishnamurthy, S, Valero, V, Rauch, GM, Shen, Y, Lin, Y, Kuerer, HM. Feasibility of breast conserving surgery alone in HER2-positive exceptional responders to neoadjuvant systemic therapy. European Journal of Surgical Oncology 50(12), 2024. e-Pub 2024. PMID: 39243728.
- Camacho L, Chu CK, Mitchell MP, Nguyen T, Correa A, Mericli AF. Oncoplastic Reconstruction in the Setting of Prior Cosmetic Augmentation. Plast Reconstr Surg 154(5):919-928, 2024. e-Pub 2024. PMID: 38376232.
- Weng, JK, Virk, R, Kaiser, KW, Hoffman, K, Goodman, C, Mitchell, MP, Shaitelman, SF, Schlembach, PJ, Reed, VK, Wu, C, Xiao, L, Smith, GL, Smith, BD. Automated, Real-Time Integration of Biometric Data From Wearable Devices With Electronic Medical Records. JCO Clinical Cancer Informatics 8, 2024. e-Pub 2024. PMID: 39348612.
- Weiss A, Colugnati F, Mitchell M, Li Y, Marin C, Gergelis KR, O'Sullivan CC, Boughey JC. ASO Visual Abstract: Contemporary Axillary Surgical Management in Patients with Pathologically Node-Positive Disease After Neoadjuvant Chemotherapy: A Survey of Members of the American Society of Breast Surgeons. Ann Surg Oncol. e-Pub 2024. PMID: 39117930.
- Kim M, Maldonado JA, Pandey P, El Alam MB, Kouzy R, Christopherson K, Minsky BD, Nugyen QN, Grosshans D, Lin LL, Mitchell MP, Klopp AH, Lee PP, Bird J, Satcher R, Lewis VO, Lin PP, Tang C, Koong AC, Moon B, Colbert LE. Single-fraction radiation retreatment for bone metastases: role of a rapid access clinic. BMJ Support Palliat Care 14(e2), 2024. e-Pub 2024. PMID: 38843933.
- Schaverien MV, Singh P, Smith BD, Qiao W, Akay CL, Bloom ES, Chavez-MacGregor M, Chu CK, Clemens MW, Colen JS, Ehlers RA, Hwang RF, Joyner MM, Largo RD, Mericli AF, Mitchell MP, Shuck JW, Tamirisa N, Tripathy D, Villa MT, Woodward WA, Zacharia R, Kuerer HM, Hoffman KE. Premastectomy Radiotherapy and Immediate Breast Reconstruction: A Randomized Clinical Trial. JAMA Netw Open 7(4):e245217, 2024. e-Pub 2024. PMID: 38578640.
- Morse RT, Moreno M, Butterworth JA, Mitchell MP. Interplay of Oncoplastic Reconstruction and Adjuvant Radiation Therapy in Breast Cancer. Adv Radiat Oncol 9(3):101403, 2024. e-Pub 2024. PMID: 38495037.
- Guhan M, Crane SM, Valerius LS, Cruz D, Smith BD, Woodward WA, Mitchell MP, Valero V, Rauch GM, Krishnamurthy S, Warnecke CL, Kuerer HM, Shaitelman SF. Patient interest in exploring non-surgical treatment approaches for early stage breast cancer: A qualitative study. Int J Radiat Oncol Biol Phys 118(2):443-454, 2024. e-Pub 2024. PMID: 37802228.
- Sun SX, Piotrowski MJ, Adesoye T, Mitchell MP, Garber HR, Teshome M, Kuerer HM, Tamirisa N, Singh P. Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement. J Am Coll Surg 238(1):1-9, 2024. e-Pub 2024. PMID: 37870227.
- Hassan AM, Asaad M, Morris N, Kumar S, Liu J, Mitchell MP, Shuck JW, Clemens MW, Butler CE, Selber JC. Subpectoral Implant Placement is not Protective Against Postmastectomy Radiotherapy-Related Complications Compared to Prepectoral Placement. Plast Reconstr Surg 153(1):24-33, 2024. e-Pub 2024. PMID: 37010459.
- Asaad M, Yu JZ, Tran JP, Liu J, O'Grady B, Clemens MW, Largo RD, Mericli AF, Schaverien M, Shuck J, Mitchell MP, Butler CE, Selber JC. Surgical and Patient-Reported Outcomes of 694 Two-Stage Prepectoral vs. Subpectoral Breast Reconstructions. Plast Reconstr Surg 152(4S):43S-54S, 2023. e-Pub 2023. PMID: 36877743.
- Baroudi H, Huy Minh Nguyen CI, Maroongroge S, Smith BD, Niedzielski JS, Shaitelman SF, Melancon A, Shete S, Whitaker TJ, Mitchell MP, Yvonne Arzu I, Duryea J, Hernandez S, El Basha D, Mumme R, Netherton T, Hoffman K, Court L. Automated contouring and statistical process control for plan quality in a breast clinical trial. Phys Imaging Radiat Oncol 28:100486, 2023. e-Pub 2023. PMID: 37712064.
- Johnson HM, Lin H, Shen Y, Diego EJ, Krishnamurthy S, Yang WT, Smith BD, Valero V, Lucci A, Sun SX, Shaitelman SF, Mitchell MP, Boughey JC, White RL, Rauch GM, Kuerer HM, Study Group ER. Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical Trial. JAMA Netw Open 6(9):e2333933, 2023. e-Pub 2023. PMID: 37707811.
- Gandhi A, Xu T, DeSnyder SM, Smith GL, Lin R, Barcenas CH, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Garner D, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I, Shaitelman SF. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program. Breast 68:205-215, 2023. e-Pub 2023. PMID: 36863241.
- Woodward WA, Mitchell MP. The Elusive Prize of Radiation Therapy Predictive Assays in Breast Cancer. Int J Radiat Oncol Biol Phys 115(1):103-105, 2023. e-Pub 2023. PMID: 36526377.
- Kuerer HM, Smith BD, Krishnamurthy S, Yang WT, Valero V, Shen Y, Lin H, Lucci A, Boughey JC, White RL, Diego EJ, Rauch GM, Trials Group ERC. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial. The Lancet 23(12):1517-1524, 2022. e-Pub 2022.
- Mitchell MP. Stage IV or Locally Advanced Disease?. Int J Radiat Oncol Biol Phys 114(4):575, 2022. e-Pub 2022. PMID: 36244392.
- Mitchell MP. High Reward and Low Risk. Int J Radiat Oncol Biol Phys 114(2):183, 2022. e-Pub 2022. PMID: 36055316.
- Aldrich MB, Rasmussen JC, DeSnyder SM, Woodward WA, Chan W, Sevick-Muraca EM, Mittendorf EA, Smith BD, Stauder MC, Strom EA, Perkins GH, Hoffman KE, Mitchell MP, Barcenas CH, Isales LE, Shaitelman SF. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging. Breast Cancer Res Treat 195(1):33-41, 2022. e-Pub 2022. PMID: 35816269.
- Diao K, Andring LM, Barcenas CH, Singh P, Carisa Le-Petross H, Reed VK, Reddy JP, Bloom ES, Ahmad NR, Mayo LL, Perkins GH, Mitchell MP, Nead KT, Tereffe W, Smith BD, Woodward WA. Contemporary Outcomes After Multimodality Therapy in Patients With Breast Cancer Presenting With Ipsilateral Supraclavicular Node Involvement. Int J Radiat Oncol Biol Phys 112(1):66-74, 2022. e-Pub 2022. PMID: 34710521.
- O'Sullivan CC, Ballman KV, McCall L, Kommalapati A, Zemla T, Weiss A, Mitchell M, Blinder V, Tung NM, Irvin WJ, Lee M, Goetz MP, Symmans WF, Borges VF, Krop I, Carey LA, Partridge AH. Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer. Future Oncol. e-Pub 2021. PMID: 34636255.
- Nia ES, Huang ML, Sun SX, Mitchell MP, Myatt JP, Candelaria RP. The mammographic appearance of the BioMonitor implantable loop recorder. Clin Imaging 73:28-30, 2021. e-Pub 2021. PMID: 33296770.
- Li XA, Moughan J, White JR, Freedman GM, Arthur DW, Galvin J, Xiao Y, McNulty S, Lyons JA, Kavadi VS, Fields MT, Mitchell MP, Anderson BM, Lock MI, Kokeny KE, Bazan JG, Currey AD, Hijal T, Cheston SB, Vicini FA. Patterns of failure observed in the two-step institution credentialing process for NRG Oncology/RTOG 1005 (NCT01349322) and lessons learned. Pract Radiat Oncol 10(4):265-273, 2020. e-Pub 2020. PMID: 31790823.
- Mamounas EP, Mitchell MP, Woodward WA. Molecular Predictive and Prognostic Markers in Locoregional Management. J Clin Oncol 38(20):JCO1902905, 2020. e-Pub 2020. PMID: 32442060.
- Butler-Xu YS, Marietta M, Zahra A, TenNapel M, Mitchell M. The effect of breast volume on toxicity using hypofractionated regimens for early stage breast cancer for patients. Adv Radiat Oncol 4(2):261-267, 2019. e-Pub 2019. PMID: 31011671.
- Myers JS, Mitchell M, Krigel S, Steinhoff A, Boyce-White A, Van Goethem K, Valla M, Dai J, He J, Liu W, Sereika SM, Bender CM. Qigong intervention for breast cancer survivors with complaints of decreased cognitive function. Support Care Cancer 27(4):1395-1403, 2019. e-Pub 2019. PMID: 30128855.
- Myers JS, Kahya M, Mitchell M, Dai J, He J, Moon S, Hamilton K, Valla M, O'Dea A, Klemp J, Kurylo M, Akinwuntan A, Devos H. Pupillary response: cognitive effort for breast cancer survivors. Support Care Cancer 27(3):1121-1128, 2019. e-Pub 2019. PMID: 30097791.
- Ganju RG, Savvides G, Korentager S, Ward MJ, TenNapel M, Amin A, Wagner J, Mitchell M. Incidence of breast lymphedema and predictors of its development in patients receiving whole breast radiation therapy after breast-conservation surgery. Lymphology(52):126-133, 2019. e-Pub 2019. PMID: 31874124.
- Kilgore LJ, Korentager SS, Hangge AN, Amin AL, Balanoff CR, Larson KE, Mitchell MP, Chen JG, Burgen E, Khan QJ, O'Dea AP, Nye L, Sharma P, Wagner JL. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions. Ann Surg Oncol 25(10):2948-2952, 2018. e-Pub 2018. PMID: 29987599.
- Mitchell MP, Wagner J, Butterworth J. Subcutaneous implant-based breast reconstruction, a modern challenge in postmastectomy radiation planning. Pract Radiat Oncol 8(3):153-156, 2018. e-Pub 2018. PMID: 29233522.
- Mallory ML, Mitchell MP. Lymphangioleiomyomatosis: A new relative contraindication for breast conservation therapy. Adv Radiat Oncol 3(1):16-18, 2018. e-Pub 2018. PMID: 29556574.
- Arguello AA, Richardson BD, Hall JL, Wang R, Hodges MA, Mitchell MP, Stuber GD, Rossi DJ, Fuchs RA. Role of a Lateral Orbital Frontal Cortex-Basolateral Amygdala Circuit in Cue-Induced Cocaine-Seeking Behavior. Neuropsychopharmacology 42(3):727-735, 2017. e-Pub 2017. PMID: 27534268.
- Stecklein SR, Shen X, Mitchell MP. Post-Mastectomy Radiation Therapy for Invasive Lobular Carcinoma: A Comparative Utilization and Outcomes Study. Clin Breast Cancer 16(4):319-26, 2016. e-Pub 2016. PMID: 26943990.
- Reddy JP, Dawood S, Mitchell M, Debeb BG, Bloom E, Gonzalez-Angulo AM, Sulman EP, Buchholz TA, Woodward WA. Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy. Radiother Oncol 117(2):308-14, 2015. e-Pub 2015. PMID: 26482599.
- Mitchell MP, Abboud M, Eng C, Beddar AS, Krishnan S, Delclos ME, Crane CH, Das P. Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity. Am J Clin Oncol 37(5):461-6, 2014. e-Pub 2014. PMID: 23466576.
- Lang JE, Tereffe W, Mitchell MP, Rao R, Feng L, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Hortobagyi GN, Babiera GV. Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival. Ann Surg Oncol 20(6):1893-9, 2013. e-Pub 2013. PMID: 23306905.
Review Articles
- Doke K, Butler S, Mitchell MP. Current Therapeutic Approaches to DCIS. J Mammary Gland Biol Neoplasia 23(4):279-291, 2018. e-Pub 2018. PMID: 30267199.
- Mitchell MP, Sharma P. The Use of Surgery and Radiotherapy as Treatment of Regional Nodes in Breast Cancer Patients. Oncology (Williston Park) 32(6):e52-e64, 2018. e-Pub 2018. PMID: 29940065.
Professional Educational Materials
- . ACR Radiation Oncology In-Training, 2021.
Abstracts
- Liu YF, Singh P, Moulder S, Woodward W, Shaitelman S, Perkins G, Lucci A, Middleton L, Smith B, Mitchell MP. Impact of Surgery Type and Radiation Fractionation on Outcomes in Node-Negative Metaplastic Breast Cancer 44(10):S41-S41, 2021.
- Goodman CR, Shaitelman S, Hoffman K, Mitchell MP, Strauss JB, Ramezani S, Zia A, Comeaux N, Virk R, Lin RT, Nead K, Stauder MC, Strom E, Perkins G, Bloom E, Reed V, Joyner M, Schlembach P, Lim B, Barcenas C, Smith BD, Lucci A, Woodward WA. Dynamics of Circulating Tumor Cell Response with Adjuvant or Pre-Operative Radiotherapy in Locally Advanced Breast Cancer: A Prospective Cohort Study 206(S1):S639-S640.
- Mitchell MP, Abboud M, Crane CH, Eng C, Chang CJ, Rodriguez-Bigas MA, Skibber JM, You YN, Beddar S, Krishnan S, Delclos M, Das P. Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancer: A large single-institution experience. Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology 30(4S).
- O'Sullivan CCM, Ballman KV, McCall LM, Zemla TJ, Weiss A, Mitchell M, Blinder VS, Tung NM, Irvin WJ, Lee M, Goetz MP, Symmans WF, Borges VF, Krop IE, Partridge AH, Cary LA. Postneoadjuvant T-DM1+tucatinib/placebo in patients with residual HER2-positive. Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) 39(15S).
- Morse R, Moreno M, Butterworth J, Mitchell MP. Interplay of Oncoplastic Reconstruction and Radiation Therapy with Associated Patient Reported Outcomes 45(9):S25-S25.
- Johnson HM, Diego EJ, Krishnamurthy S, Yang W, Smith B, Valero V, Lucci A, Shaitelman S, Mitchell M, Boughey JC, White R, Rauch G, Kuerer H. Multicenter Clinical Trial for Omission of Breast Surgery on Invasive Cancer Following Neoadjuvant Systemic Therapy: Longitudinal Patient Reported Outcomes and Decisional Comfort Planned Analyses. Annual International Conference of the Society-of-Surgical-Oncology (SSO) on Surgical Cancer Care 30(SUPPL1):S11-S12.
- Kuerer H, Smith B, Valero V, Krishnamurthy S, Diego E, Yang W, Shen Y, Lucci A, Lin H, Johnson H, Moseley T, Boughey JC, Shaitelman S, White R, Mitchell M, Teshome M, Miggins M, Hunt KK, Rauch GM. Eliminating breast surgery for invasive cancer after neoadjuvant systemic therapy: 5-year outcomes on an inaugural multicenter phase 2 clinical trial. Meeting of the Society-of-Surgical-Oncology 32(S1):S28-S28.
Book Chapters
- Moscol G, Hwang R, Mitchell M. Breast Cancer. In: Gynecologic Care of the Female Cancer Patient, 2023.
- Amin A, Mitchell M. Axillary surgery vs Radiation as treatment of regional nodes: AMAROS trial and beyond. In: Spear's Surgery of the Breast: Principles and Art. 4e edited by Allen Gabriel, 2020, 2020.
Patient Reviews
CV information above last modified March 18, 2026